CB1 Capital Management predicts Cannabis could disrupt the healthcare industry in a big way. The firm's Founding Partner and Chief Investment Officer Todd Harrison explains why he thinks medical marijuana will migrate from state dispensaries, to become medicine prescribed by doctors through insurance in the next decade.
Harrison says the only way the U.S. government would get their hands on the money in this market opportunity is through the FDA. "That's where we think it goes, follow the money," says Harrison.
"This is not so much a trade about commerce, as it is a trade about healthcare," said Harrison. "We think that this is going to migrate towards medicine." One of CB1 Capital Management's holdings GW Pharmaceuticals is up 30 percent over the past three months. Harrison expects this company to publish research showing the efficacy of cannabis treatment this summer.
Ryan Hamburger, Chief Commercial Officer at Instacart, explains how Clementine uses AI to personalize grocery shopping, build carts, find deals, and save time.
Ari Hawkins, Trade Reporter at POLITICO, examines Canada’s retaliation, Trump’s latest trade threats and the potential impact on businesses and consumers.
Dan Mohnshine, Hershey’s VP of Creation Strategy & Innovation, discusses the brand’s premium chocolate push and strategy to connect with younger consumers.
